TY - JOUR
T1 - Tissue accumulation of neutrophil extracellular traps mediates muscle hyperalgesia in a mouse model
AU - Suzuki, Kazuaki
AU - Tsuchiya, Masahiro
AU - Yoshida, Shinichirou
AU - Ogawa, Kazumi
AU - Chen, Weijian
AU - Kanzaki, Makoto
AU - Takahashi, Tadahisa
AU - Fujita, Ryo
AU - Li, Yuqing
AU - Yabe, Yutaka
AU - Aizawa, Toshimi
AU - Hagiwara, Yoshihiro
N1 - Funding Information:
The authors are grateful to Dr. Shigenori Sekiai, Dr. Chayanit Chaweewannakorn, and Ms. Natsumi Emoto at the Tohoku University Graduate School of Biomedical Engineering for their technical assistance, and Dr. Hiroyuki Tada at the Tohoku University Graduate School of Dentistry for the excellent advice on the study. We also would like to thank the other doctors at the Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, for their exceptional technical advice in this study.
Funding Information:
This work was supported in part by grants from the Japan Society for the Promotion of Science (Nos. 16K11580 and 19K10229 to MT).
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Accumulation of uric acid (UA) during muscular trauma is a factor involved in the development of muscle hyperalgesia. Neutrophil extracellular traps (NETs), DNA-based reticular structures to capture UA, play a central role in the pain onset of gout attacks; however, the involvement of NETs via the elevation of local UA level in muscle hyperalgesia due to injuries from muscle overuse remains unknown. The triceps surae muscles (TSMs) in the unilateral hindlimb of mice were electrically stimulated to induce excessive muscle contraction. Mechanical withdrawal thresholds, tissue UA levels, neutrophil recruitment, and protein amount of citrullinated histone 3 (citH3), a major marker of NETs, were investigated. Furthermore, whether neutrophil depletion, extracellular DNA cleavage, and administration of the urate-lowering agent febuxostat improved muscle hyperalgesia caused by NET formation was examined. CitH3 expression upon neutrophil recruitment was significantly increased in the stimulated TSMs with increased tissue UA levels, whereas febuxostat administration improved muscle hyperalgesia with decreased citH3 and tissue UA levels, as observed in neutrophil depletion and extracellular DNA digestion. The underlying mechanism of muscle hyperalgesia associated with locally recruited neutrophils forming NETs due to increased tissue UA levels potentially plays a significant role in creating a vicious circle of muscle pain.
AB - Accumulation of uric acid (UA) during muscular trauma is a factor involved in the development of muscle hyperalgesia. Neutrophil extracellular traps (NETs), DNA-based reticular structures to capture UA, play a central role in the pain onset of gout attacks; however, the involvement of NETs via the elevation of local UA level in muscle hyperalgesia due to injuries from muscle overuse remains unknown. The triceps surae muscles (TSMs) in the unilateral hindlimb of mice were electrically stimulated to induce excessive muscle contraction. Mechanical withdrawal thresholds, tissue UA levels, neutrophil recruitment, and protein amount of citrullinated histone 3 (citH3), a major marker of NETs, were investigated. Furthermore, whether neutrophil depletion, extracellular DNA cleavage, and administration of the urate-lowering agent febuxostat improved muscle hyperalgesia caused by NET formation was examined. CitH3 expression upon neutrophil recruitment was significantly increased in the stimulated TSMs with increased tissue UA levels, whereas febuxostat administration improved muscle hyperalgesia with decreased citH3 and tissue UA levels, as observed in neutrophil depletion and extracellular DNA digestion. The underlying mechanism of muscle hyperalgesia associated with locally recruited neutrophils forming NETs due to increased tissue UA levels potentially plays a significant role in creating a vicious circle of muscle pain.
UR - http://www.scopus.com/inward/record.url?scp=85126077812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126077812&partnerID=8YFLogxK
U2 - 10.1038/s41598-022-07916-8
DO - 10.1038/s41598-022-07916-8
M3 - Article
C2 - 35264677
AN - SCOPUS:85126077812
SN - 2045-2322
VL - 12
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 4136
ER -